88 research outputs found
A Polyclonal Immune Function Assay Allows Dose-Dependent Characterization of Immunosuppressive Drug Effects but Has Limited Clinical Utility for Predicting Infection on an Individual Basis
Dosage of immunosuppressive drugs after transplantation critically determines rejection and infection episodes. In this study, a global immune function assay was characterized among controls, dialysis-patients, and transplant-recipients to evaluate its utility for pharmacodynamic monitoring of immunosuppressive drugs and for predicting infections. Whole-blood samples were stimulated with anti-CD3/toll-like-receptor (TLR7/8)-agonist in the presence or absence of drugs and IFN-γ secretion was measured by ELISA. Additional stimulation-induced cytokines were characterized among T-, B-, and NK-cells using flow-cytometry. Cytokine-secretion was dominated by IFN-γ, and mainly observed in CD4, CD8, and NK-cells. Intra-assay variability was low (CV = 10.4 ± 6.2%), whereas variability over time was high, even in the absence of clinical events (CV = 65.0 ± 35.7%). Cyclosporine A, tacrolimus and steroids dose-dependently inhibited IFN-γ secretion, and reactivity was further reduced when calcineurin inhibitors were combined with steroids. Moreover, IFN-γ levels significantly differed between controls, dialysis-patients, and transplant-recipients, with lowest IFN-γ levels early after transplantation (p < 0.001). However, a single test had limited ability to predict infectious episodes. In conclusion, the assay may have potential for basic pharmacodynamic characterization of immunosuppressive drugs and their combinations, and for assessing loss of global immunocompetence after transplantation, but its application to guide drug-dosing and to predict infectious on an individual basis is limited
Calcineurin inhibitors differentially alter the circadian rhythm of T-cell functionality in transplant recipients
Background: Graft survival in transplant recipients depends on pharmacokinetics and on individual susceptibility
towards immunosuppressive drugs. Nevertheless, pharmacodynamic changes in T-cell functionality in response to
drugs and in relation to pharmacokinetics are poorly characterized. We therefore investigated the immunosuppressive
effect of calcineurin inhibitors and steroids on general T-cell functionality after polyclonal stimulation of whole blood
samples.
Methods: General T-cell functionality in the absence or presence of immunosuppressive drugs was determined in vitro
directly from whole blood based on cytokine induction after stimulation with the polyclonal stimulus Staphylococcus
aureus enterotoxin B. In addition, diurnal changes in leukocyte and lymphocyte subsets, and on T-cell function after
intake of immunosuppressive drugs were analyzed in 19 patients during one day and compared to respective kinetics
in six immunocompetent controls. Statistical analysis was performed using non-parametric and parametric tests.
Results: Susceptibility towards calcineurin inhibitors showed interindividual differences. When combined with steroids,
tacrolimus led to more pronounced increase in the inhibitory activity as compared to cyclosporine A. While circadian
alterations in leukocyte subpopulations and T-cell function in controls were related to endogenous cortisol levels, T-cell
functionality in transplant recipients decreased after intake of the morning medication, which was more pronounced in
patients with higher drug-dosages. Interestingly, calcineurin inhibitors differentially affected circadian rhythm of T-cell
function, as patients on cyclosporine A showed a biphasic decrease in T-cell reactivity after drug-intake in the morning
and evening, whereas T-cell reactivity in patients on tacrolimus remained rather stable.
Conclusions: The whole blood assay allows assessment of the inhibitory activity of immunosuppressive drugs in
clinically relevant concentrations. Circadian alterations in T-cell function are determined by dose and type of
immunosuppressive drugs and show distinct differences between cyclosporine A and tacrolimus. In future these
findings may have practical implications to estimate the net immunosuppressive effect of a given drug-regimen
that daily acts in an individual patient, and may contribute to individualize immunosuppressio
Calcineurin inhibitors differentially alter the circadian rhythm of T-cell functionality in transplant recipients
Background: Graft survival in transplant recipients depends on pharmacokinetics and on individual susceptibility
towards immunosuppressive drugs. Nevertheless, pharmacodynamic changes in T-cell functionality in response to
drugs and in relation to pharmacokinetics are poorly characterized. We therefore investigated the immunosuppressive
effect of calcineurin inhibitors and steroids on general T-cell functionality after polyclonal stimulation of whole blood
samples.
Methods: General T-cell functionality in the absence or presence of immunosuppressive drugs was determined in vitro
directly from whole blood based on cytokine induction after stimulation with the polyclonal stimulus Staphylococcus
aureus enterotoxin B. In addition, diurnal changes in leukocyte and lymphocyte subsets, and on T-cell function after
intake of immunosuppressive drugs were analyzed in 19 patients during one day and compared to respective kinetics
in six immunocompetent controls. Statistical analysis was performed using non-parametric and parametric tests.
Results: Susceptibility towards calcineurin inhibitors showed interindividual differences. When combined with steroids,
tacrolimus led to more pronounced increase in the inhibitory activity as compared to cyclosporine A. While circadian
alterations in leukocyte subpopulations and T-cell function in controls were related to endogenous cortisol levels, T-cell
functionality in transplant recipients decreased after intake of the morning medication, which was more pronounced in
patients with higher drug-dosages. Interestingly, calcineurin inhibitors differentially affected circadian rhythm of T-cell
function, as patients on cyclosporine A showed a biphasic decrease in T-cell reactivity after drug-intake in the morning
and evening, whereas T-cell reactivity in patients on tacrolimus remained rather stable.
Conclusions: The whole blood assay allows assessment of the inhibitory activity of immunosuppressive drugs in
clinically relevant concentrations. Circadian alterations in T-cell function are determined by dose and type of
immunosuppressive drugs and show distinct differences between cyclosporine A and tacrolimus. In future these
findings may have practical implications to estimate the net immunosuppressive effect of a given drug-regimen
that daily acts in an individual patient, and may contribute to individualize immunosuppressio
Cellular immunity predominates over humoral immunity after homologous and heterologous mRNA and vector-based COVID-19 vaccine regimens in solid organ transplant recipients
Knowledge on the immunogenicity of vector-based and mRNA-vaccines in solid organ
transplant recipients is limited. Therefore, SARS-CoV-2–specific T cells and antibodies were analyzed in 40 transplant recipients and 70 controls after homologous or
heterologous vaccine-regimens. Plasmablasts and SARS-CoV-2–specific CD4 and
CD8 T cells were quantified using flow cytometry. Specific antibodies were analyzed
by ELISA and neutralization assay. The two vaccine types differed after the first vaccination, as IgG and neutralizing activity were more pronounced after mRNA priming
(p = .0001 each), whereas CD4 and CD8 T cell levels were higher after vector priming
(p = .009; p = .0001). All regimens were well tolerated, and SARS-CoV-2–specific antibodies and/or T cells after second vaccination were induced in 100% of controls and
70.6% of transplant recipients. Although antibody and T cell levels were lower in patients, heterologous vaccination led to the most pronounced induction of antibodies
and CD4 T cells. Plasmablast numbers were significantly higher in controls and correlated with SARS-CoV-2–specific IgG- and T cell levels. While antibodies were only
detected in 35.3% of patients, cellular immunity was more frequently found (64.7%)
indicating that assessment of antibodies is insufficient to identify COVID-19-vaccine
responders. In conclusion, heterologous vaccination seems promising in transplant recipients, and combined analysis of humoral and cellular immunity improves the identification of responders among immunocompromised individuals
Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients
<p>Abstract</p> <p>Background</p> <p>Cytomegalovirus (CMV) seronegative recipients (R-) of kidney transplants (KT) from seropositive donors (D+) are at higher risk for CMV replication and ganciclovir(GCV)-resistance than CMV R(+). We hypothesized that low CMV-specific T-cell responses are associated with increased risk of CMV replication in R(+)-patients with D(+) or D(-) donors.</p> <p>Methods</p> <p>We prospectively evaluated 73 consecutive KT-patients [48 R(+), 25 D(+)R(-)] undergoing routine testing for CMV replication as part of a preemptive strategy. We compared CMV-specific interferon-Îł (IFN-Îł) responses of CD4+CD3+ lymphocytes in peripheral blood mononuclear cells (PBMC) using three different antigen preparation (CMV-lysate, pp72- and pp65-overlapping peptide pools) using intracellular cytokine staining and flow cytometry.</p> <p>Results</p> <p>Median CD4+ and CD8+T-cell responses to CMV-lysate, pp72- and pp65-overlapping peptide pools were lower in D(+)R(-) than in R(+)patients or in non-immunosuppressed donors. Comparing subpopulations we found that CMV-lysate favored CD4+- over CD8+-responses, whereas the reverse was observed for pp72, while pp65-CD4+- and -CD8+-responses were similar. Concurrent CMV replication in R(+)-patients was associated with significantly lower T-cell responses (pp65 median CD4+ 0.00% vs. 0.03%, p = 0.001; CD8+ 0.01% vs. 0.03%; p = 0.033). Receiver operated curve analysis associated CMV-pp65 CD4+ responses of > 0.03% in R(+)-patients with absence of concurrent (p = 0.003) and future CMV replication in the following 8 weeks (p = 0.036). GCV-resistant CMV replication occurred in 3 R(+)-patients (6.3%) with pp65- CD4+ frequencies < 0.03% (p = 0.041).</p> <p>Conclusion</p> <p>The data suggest that pp65-specific CD4+ T-cells might be useful to identify R(+)-patients at increased risk of CMV replication. Provided further corroborating evidence, CMV-pp65 CD4+ responses above 0.03% in PBMCs of KT patients under stable immunosuppression are associated with lower risk of concurrent and future CMV replication during the following 8 weeks.</p
Whole-Blood Flow-Cytometric Analysis of Antigen-Specific CD4 T-Cell Cytokine Profiles Distinguishes Active Tuberculosis from Non-Active States
T-cell based IFN-γ release assays do not permit distinction of active tuberculosis (TB) from successfully treated disease or latent M. tuberculosis infection. We postulated that IFN-γ and IL-2 cytokine profiles of antigen-specific T cells measured by flow-cytometry ex vivo might correlate with TB disease activity in vivo. Tuberculin (PPD), ESAT-6 and CFP-10 were used as stimuli to determine antigen-specific cytokine profiles in CD4 T cells from 24 patients with active TB and 28 patients with successfully treated TB using flow-cytometry. Moreover, 25 individuals with immunity consistent with latent M. tuberculosis infection and BCG-vaccination, respectively, were recruited. Although the frequency of cytokine secreting PPD reactive CD4 T cells was higher in patients with active TB compared to patients with treated TB (median 0.81% vs. 0.39% of CD4 T cells, p = 0.02), the overlap in frequencies precluded distinction between the groups on an individual basis. When assessing cytokine profiles, PPD specific CD4 T cells secreting both IFN-γ and IL-2 predominated in treated TB, latent infection and BCG-vaccination, whilst in active TB the cytokine profile was shifted towards cells secreting IFN-γ only (p<0.0001). Cytokine profiles of ESAT-6 or CFP-10 reactive CD4 T cells did not differ between the groups. Receiver operator characteristics (ROC) analysis revealed that frequencies of PPD specific IFN-γ/IL-2 dual-positive T cells below 56% were an accurate marker for active TB (specificity 100%, sensitivity 70%) enabling effective discrimination from non-active states. In conclusion, a frequency lower than 56% IFN-γ/IL-2 dual positive PPD-specific circulating CD4 T-cells is strongly indicative of active TB
Immunogenicity and reactogenicity of a heterologous COVID-19 prime-boost vaccination compared with homologous vaccine regimens
Heterologous priming with the ChAdOx1-nCoV-19 vector-vaccine followed by boosting with an mRNA-vaccine is currently recommended in Germany, although data on immunogenicity and reactogenicity are not available. Here we show that the heterologous regimen induced spike-specific IgG, neutralizing antibodies, and spike-specific CD4 T-cells, which were significantly more pronounced than after homologous vector boost, and higher or comparable in magnitude to the homologous mRNA regimens. Moreover, spike-specific CD8 T-cell levels after heterologous vaccination were significantly higher than after both homologous regimens. Cytokine expression profiling showed a predominance of polyfunctional T-cells expressing IFNγ, TNFα and IL-2 with subtle differences between regimens. Both recipients of the homologous vector-regimen and the heterologous vector/mRNA-combination were most affected by the priming vector-vaccination, whereas heterologous boosting was well tolerated and comparable to homologous mRNA-boosting. Taken together, heterologous vector-mRNA boosting induces strong humoral and cellular immune responses with acceptable reactogenicity profile. This knowledge will have implications for future vaccine strategies
Alterations in pathogen-specific cellular and humoral immunity associated with acute peripheral facial palsy of infectious origin
Background Peripheral facial palsy (PFP) is a common neurologic symptom which can be triggered by pathogens, autoimmunity, trauma, tumors, cholesteatoma or further local conditions disturbing the peripheral section
of the nerve. In general, its cause is often difcult to identify, remaining unknown in over two thirds of cases. As we
have previously shown that the quantity and quality of pathogen-specifc T cells change during active infections, we
hypothesized that such changes may also help to identify the causative pathogen in PFPs of unknown origin.
Methods In this observational study, pathogen-specifc T cells were quantifed in blood samples of 55 patients
with PFP and 23 healthy controls after stimulation with antigens from varicella-zoster virus (VZV), herpes-simplex
viruses (HSV) or borrelia. T cells were further characterized by expression of the inhibitory surface molecule CTLA-4,
as well as markers for diferentiation (CD27) and proliferation (Ki67). Pathogen-specifc antibody responses were analyzed using ELISA. Results were compared with conventional diagnostics.
Results Patients with PFP were more often HSV-seropositive than controls (p=0.0003), whereas VZV- and borreliaspecifc antibodies did not difer between groups. Although the quantity and general phenotypical characteristics
of antigen-specifc T cells did not difer either, expression of CTLA-4 and Ki67 was highly increased in VZV-specifc
T cells of 9 PFP patients, of which 5 showed typical signs of cutaneous zoster. In the remaining 4 patients, a causal
relationship with VZV was possible but remained unclear by clinical standard diagnostics. A similar CTLA-4- and Ki67-
expression profle of borrelia-specifc T cells was also found in a patient with acute neuroborreliosis.
Discussion In conclusion, the high prevalence of HSV-seropositivity among PFP-patients may indicate an underestimation of HSV-involvement in PFP, even though HSV-specifc T cell characteristics seem insufcient to identify HSV
as a causative agent. In contrast, striking alterations in VZV- and borrelia-specifc T cell phenotype and function may
allow identifcation of VZV- and borrelia-triggered PFPs. If confrmed in larger studies, antigen-specifc immune-phenotyping may have the potential to improve specifcity of the clinical diagnosis
High levels of SARS-CoV-2 specific T-cells with restricted functionality in patients with severe course of COVID-19
Patients infected with SARS-CoV-2 differ in the severity of disease. In this study, SARS-CoV-2 specific T-cells and antibodies were characterized in patients with different COVID-19 related disease severity. Despite severe lymphopenia affecting all major lymphocyte subpopulations, patients with severe disease mounted significantly higher levels of SARS-CoV-2 specific T-cells as compared to convalescent individuals. SARS-CoV-2 specific CD4 T-cells dominated over CD8 T-cells and closely correlated with the number of plasmablasts and SARS-CoV-2 specific IgA- and IgG-levels. Unlike in convalescents, SARS-CoV-2 specific T-cells in patients with severe disease showed marked alterations in phenotypical and functional properties, which also extended to CD4 and CD8 T-cells in general. Given the strong induction of specific immunity to control viral replication in patients with severe disease, the functionally altered phenotype may result from the need for contraction of specific and general immunity to counteract excessive immunopathology in the lung
High levels of SARS-CoV-2-specific T cells with restricted functionality in severe courses of COVID-19
BACKGROUND. Patients infected with severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) differ in the severity of disease. We hypothesized that characteristics of SARS-CoV-2–
specific immunity correlate with disease severity.
METHODS. In this study, SARS-CoV-2–specific T cells and antibodies were characterized in
uninfected controls and patients with different coronavirus disease 2019 (COVID-19) disease
severity. SARS-CoV-2–specific T cells were flow cytometrically quantified after stimulation with
SARS-CoV-2 peptide pools and analyzed for expression of cytokines (IFN-γ, IL-2, and TNF-α)
and markers for activation, proliferation, and functional anergy. SARS-CoV-2–specific IgG and
IgA antibodies were quantified using ELISA. Moreover, global characteristics of lymphocyte
subpopulations were compared between patient groups and uninfected controls.
RESULTS. Despite severe lymphopenia affecting all major lymphocyte subpopulations, patients
with severe disease mounted significantly higher levels of SARS-CoV-2–specific T cells as compared
with convalescent individuals. SARS-CoV-2–specific CD4+
T cells dominated over CD8+
T cells and
closely correlated with the number of plasmablasts and SARS-CoV-2–specific IgA and IgG levels.
Unlike in convalescent patients, SARS-CoV-2–specific T cells in patients with severe disease showed
marked alterations in phenotypical and functional properties, which also extended to CD4+
and CD8+
T cells in general.
CONCLUSION. Given the strong induction of specific immunity to control viral replication in
patients with severe disease, the functionally altered characteristics may result from the need for
contraction of specific and general immunity to counteract excessive immunopathology in the lung.
FUNDING. The study was supported by institutional funds to MS and in part by grants of Saarland
University, the State of Saarland, and the Rolf M. Schwiete Stiftung
- …